Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2026-01-03 @ 5:53 PM
Study NCT ID:
NCT03138161
Status:
RECRUITING
Last Update Posted:
2025-02-24
First Post:
2017-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma
Sponsor:
Sarcoma Oncology Research Center, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-13
Start Date Type:
ACTUAL
Primary Completion Date:
2030-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-07-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-04-14
First Submit QC Date:
None
Study First Post Date:
2017-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-24
Last Update Post Date Type:
ACTUAL